Disclaimer

The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • 7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • +886-2-77201070
  • info@gravitycapital.com
  • Disclaimer

    The information contained in this website is for general information purposes only. The information is provided by Gravity Capital and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

    In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

  • address:
    7F, NO. 1, Aly. 30, Ln. 358, Ruiguang RD., Neihu Dist., Taipei City 11492, Taiwan
  • tel:
    +886-2-77201070
  • email:
    info@gravitycapital.com
  • “The Fight Against the Pandemic and Me”--- Multiple Sinovision Product Conducted into Key Product Directory

    Release time: 2020-04-03Number of visits:428author:admin

    Ever since the breakout of the COVID-19 pandemic, the need for medical equipment on all levels of domestic medical agencies has increased dramatically. In order to support frontline medical institutions to efficiently acquire medical equipment, control and contain the outbreak, every related departments released their recommended medical equipment directory, and Sinovision was elected as one of them as a domestic CT manufacturer.

    This directory has 3 key features: The First being all technological products and services has exhibited the self-starting innovation of ZhongGuan Village. All technological products and services have independent intellectual property rights, most technologies are leading with the country, and some leading in the world. The second is that they are all closely related to the combat against the pandemic. Technologies within the list covers products and services such as virus detection, vaccine development, clinical treatments, medical protection, smart diagnostics, pandemic analysis and so on. The third focus lay on the fact that most if not all the technologies are mature and well-developed, and can be used immediately against the pandemic.

    To better realize the potential efficacies within universities, institutions, and technology companies in supporting the technological and supply need in the combat against the pandemic, the Department of Technology asked the broader society to contribute new technologies and new products specifically targeting the pandemic and re-opening of production, and after sorting, compiled a list of such new technologies and products(First wave has 283 items), Sinovision was listed among them.

    Since its founding, Sinovision has always placed its focus on the independent research and development of its products, complete control over its core technologies and patents, and has achieved product placements worldwide. This pandemic is a challenge for the people of China, but also a challenge for the domestic producers of medical equipment.